pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3171 |
Genomic Coordinates | chr14: 27633205 - 27633278 |
Description | Homo sapiens miR-3171 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3171 | ||||||||||||||||||
Sequence | 10| AGAUGUAUGGAAUCUGUAUAUAUC |33 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | H3F3B | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Synonyms | H3.3B | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Description | H3 histone family member 3B | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transcript | NM_005324 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Expression | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Putative miRNA Targets on H3F3B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3'UTR of H3F3B (miRNA target sites are highlighted) |
>H3F3B|NM_005324|3'UTR 1 GTGAAGGCAGTTTTTATGGCGTTTTGTAGTAAATTCTGTAAAATACTTTGGTTTAATTTGTGACTTTTTTTGTAAGAAAT 81 TGTTTATAATATGTTGCATTTGTACTTAAGTCATTCCATCTTTCACTCAGGATGAATGCGAAAAGTGACTGTTCACAGAC 161 CTCAGTGATGTGAGCACTGTTGCTCAGGAGTGACAAGTTGCTAATATGCAGAAGGGATGGGTGATACTTCTTGCTTCTCA 241 TGATGCATGTTTCTGTATGTTAATGACTTGTTGGGTAGCTATTAAGGTACTAGAGTTGATAAATGTGTACAGGGTCCTTT 321 TGCAATAAAACTGGTTATGACTTGATCCAAGTGTTTAACAATTGGGGCTGTTAAGTCTGACCATACATCACTGTGATAGA 401 ATGTGGGCTTTTTCAAGGGTGAAGATACAAGTCTTAACCACAGTGTAACTTACAGTTTCCTTTAAAAAAAAAAAAAGTAA 481 ACCTGGCAGCTATAGAATACACTATGTGCATTTATAATAGCTATTTTATATATTGTAGTATCAACATTTTTAAATTAAAT 561 GTTTTACATTCACAAGTGGTGGGGAGTCTTGTCATTAAGGTGTGTGTAATTTAGAGTCCAGTTGGTTTTCTTCTGACTGC 641 ACTTGTTCTCATAGTAGTAAAATGCTATGCGCATTTATACCTTGCATAAGTCCTCATTCTACCACATGTTAACCCTCTAG 721 CTGATAATGCAAACACTAACTGGGGGATTTTATTTATAAGGGCTCTAGAAAAAACGAGTTATTCACACCAGCATCATCTT 801 AACTAACATTCTGAACTAGTTAGTGCAGCTTTTCATTGTGTTGTGTGGTTGGTCTCATAACTAGGTTGAGTTTTTCTCCT 881 CTGCTGAGGAAACAGTACCGAAGTTCTTTTTCTTGTGGCATTTGTATTATAAAAACTTGGTGTGGGGGAGGAGCACAAAA 961 CTCCAGCCCACTGAACCTCTGCCAATTAAGATGGTGTTGGGTTAGGTTACATCTGGTTACTGTCCTGGGAAAATCATTTT 1041 TATAGAGATGGCCTTCCAAGTGGTTTTAAAATTTACTGAAGTTTTTAGGTCAATTATGTATGTTGACTAAATTTACAAAT 1121 AAACTTGTTTATCCAACTAAGTGTCCAAAACCTAAATTGAATGTACTAAGTTTTCACATGTCCCATTATCTAGGTCCTTG 1201 TATACTAATGTTTTGAACTTAGATCATTTCAGGTGTTGTTTGGTGGATAAAGGAACCTTTTATTTATAAAGATACTGTAG 1281 AAAGCATGTGAACAGCTCTCTGCTTGATTAAGATGCCATAATAGTGCTGTATTTGCAGTGTGGGCTAAGACAAAGTATAT 1361 TAATAAGCTTTTCAGCCCCCCCACTCCCGTTCCGTAGTGTAGAAGCCCACAGGTGTAGAACTCAGTCTTAAACTTCAGTA 1441 TGAAACCAGTTTCCTTGTGCGATGATGGCCACTAAAGCATAGTACGTGGATGTCAGTGAGACAGCATGAGAGCCAGCAGT 1521 CATCAAAGCGTTCCACGTTTGAAGTTAGCAACTGCTTAAAGTTATGCCCCATTAAAATTGCTTTCTCAAAAGTTTGGGTT 1601 AGTTTCAAATGTGATATTTTGGAGGGAAGGTAAAGTAGGTATCTTTCAGGTCGTGATAATGAGCTCCTATGAAAGGATGC 1681 AATATAATGACCCGCTTTTCTAGAAAGTTCATAATCAGCTCTGGAACAAGCACACTTGATTCCTCACTGTGCTTCAGAAT 1761 GAGATTAAGATCAGATGTTGGAACGTGCTATGCTGTAGCGTGTCTGGAAACAAAGTACACAAACCTGGCTACGGTGATGA 1841 GTTAGCTTCTGCTTACTACCTGTGACAACCCAAGTGGGTGACACTAGTGAACCTTCTCCAGTCTGCAGGCTGGCATAGAA 1921 GGCTCTTAGATTATATTGGGCAGCTTGCAATCTGCCGAAGCAGTGACTTGCATTTCCACACTTGGCTTGAGCACTCAACC 2001 CAGAAGGCGAAGATAGCTTTTGGTTGTAGGCGGCTTCCTGTATGGGATATCCCTCGGTAAGGGTAAAGGAGCAGAGGCAA 2081 AGGAGAAAAGCAGAAGTTGCAGCTGATGCAGGTATCCTATGCCCTTGATGGATGAGACTAAAATAAAATTTTTGAAGTTA 2161 AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DRVs in gene 3'UTRs |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SNPs in gene 3'UTRs |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset GSM4903825 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID14_NS |
Location of target site | NM_005324 | 3UTR | GACCAUACAUCACUGUGAUAGAAUGUGGGCUUUUUCAAGGGUGAAGAUACAAGUCUUAACCACA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_005324 | 3UTR | UUUUGUAGUAAAUUCUGUAAAAUACUUUGGUUUAAUUUGUGACUUUUUUUGUAAGAAAUUGUUUAUAAUAUGUUGCAUUUGUACUUAAGUCAUUCCAUCUUUCACUCAGGAUGAAUGCGAAAAGUGACUGUUCACAGACCUCAGUGAUGUGAGCACUGUUGCUCAGGAGUGACAAGUUGCUAAUAUGCAGAAGGGAUGGGUGAUACUUCUUGCUUCUCAUGAUGCAUGUUUCUGUAUGUUAAUGACUUGUUGGGUAGCUAUUAAGGUACUAGAGUUGAUAAAUGUGUACAGGGUCCUUUUGCAAUAAAACUGGUUAUGACUUGAUCCAAGUGUUUAACAAUUGGGGCUGUUAAGUCUGACCAUACAUCACUGUGAUAGAAUGUGGGCUUUUUCAAGGGUGAAGAUACAAGUCUUAACCACA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_005324 | 3UTR | AAGGCAGUUUUUAUGGCGUUUUGUAGUAAAUUCUGUAAAAUACUUUGGUUUAAUUUGUGACUUUUUUUGUAAGAAAUUGUUUAUAAUAUGUUGCAUUUGUACUUAAGUCAUUCCAUCUUUCACUCAGGAUGAAUGCGAAAAGUGACUGUUCACAGACCUCAGUGAUGUGAGCACUGUUGCUCAGGAGUGACAAGUUGCUAAUAUGCAGAAGGGAUGGGUGAUACUUCUUGCUUCUCAUGAUGCAUGUUUCUGUAUGUUAAUGACUUGUUGGGUAGCUAUUAAGGUACUAGAGUUGAUAAAUGUGUACAGGGUCCUUUUGCAAUAAAACUGGUUAUGACUUGAUCCAAGUGUUUAACAAUUGGGGCUGUUAAGUCUGACCAUACAUCACUGUGAUAGAAUGUGGGCUUUUUCAAGGGUGAAGAUACAAGUCUUAACCACA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_005324 | 3UTR | AGUUUUUAUGGCGUUUUGUAGUAAAUUCUGUAAAAUACUUUGGUUUAAUUUGUGACUUUUUUUGUAAGAAAUUGUUUAUAAUAUGUUGCAUUUGUACUUAAGUCAUUCCAUCUUUCACUCAGGAUGAAUGCGAAAAGUGACUGUUCACAGACCUCAGUGAUGUGAGCACUGUUGCUCAGGAGUGACAAGUUGCUAAUAUGCAGAAGGGAUGGGUGAUACUUCUUGCUUCUCAUGAUGCAUGUUUCUGUAUGUUAAUGACUUGUUGGGUAGCUAUUAAGGUACUAGAGUUGAUAAAUGUGUACAGGGUCCUUUUGCAAUAAAACUGGUUAUGACUUGAUCCAAGUGUUUAACAAUUGGGGCUGUUAAGUCUGACCAUACAUCACUGUGAUAGAAUGUGGGCUUUUUCAAGGGUGAAGAUACAAGUCUUAACCACA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_005324 | 3UTR | UGGCGUUUUGUAGUAAAUUCUGUAAAAUACUUUGGUUUAAUUUGUGACUUUUUUUGUAAGAAAUUGUUUAUAAUAUGUUGCAUUUGUACUUAAGUCAUUCCAUCUUUCACUCAGGAUGAAUGCGAAAAGUGACUGUUCACAGACCUCAGUGAUGUGAGCACUGUUGCUCAGGAGUGACAAGUUGCUAAUAUGCAGAAGGGAUGGGUGAUACUUCUUGCUUCUCAUGAUGCAUGUUUCUGUAUGUUAAUGACUUGUUGGGUAGCUAUUAAGGUACUAGAGUUGAUAAAUGUGUACAGGGUCCUUUUGCAAUAAAACUGGUUAUGACUUGAUCCAAGUGUUUAACAAUUGGGGCUGUUAAGUCUGACCAUACAUCACUGUGAUAGAAUGUGGGCUUUUUCAAGGGUGAAGAUACAAGUCUUAACCACA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_005324 | 3UTR | ACUUGAUCCAAGUGUUUAACAAUUGGGGCUGUUAAGUCUGACCAUACAUCACUGUGAUAGAAUGUGGGCUUUUUCAAGGGUGAAGAUACAAGUCUUAACCACA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_005324 | 3UTR | UGAAGGCAGUUUUUAUGGCGUUUUGUAGUAAAUUCUGUAAAAUACUUUGGUUUAAUUUGUGACUUUUUUUGUAAGAAAUUGUUUAUAAUAUGUUGCAUUUGUACUUAAGUCAUUCCAUCUUUCACUCAGGAUGAAUGCGAAAAGUGACUGUUCACAGACCUCAGUGAUGUGAGCACUGUUGCUCAGGAGUGACAAGUUGCUAAUAUGCAGAAGGGAUGGGUGAUACUUCUUGCUUCUCAUGAUGCAUGUUUCUGUAUGUUAAUGACUUGUUGGGUAGCUAUUAAGGUACUAGAGUUGAUAAAUGUGUACAGGGUCCUUUUGCAAUAAAACUGGUUAUGACUUGAUCCAAGUGUUUAACAAUUGGGGCUGUUAAGUCUGACCAUACAUCACUGUGAUAGAAUGUGGGCUUUUUCAAGGGUGAAGAUACAAGUCUUAACCACA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM545212 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000591890.1 | 3UTR | ACCAUACAUCACUGUGAUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000591890.1 | 3UTR | ACCAUACAUCACUGUGAUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 10 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000591890.1 | 3UTR | UAAGUCUGACCAUACAUCACUGUGAUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 11 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000591890.1 | 3UTR | ACCAUACAUCACUGUGAUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 12 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000591890.1 | 3UTR | UCUGACCAUACAUCACUGUGAUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
37 hsa-miR-3171 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT117345 | MAPRE2 | microtubule associated protein RP/EB family member 2 | 2 | 2 | ||||||||
MIRT152426 | ARID3A | AT-rich interaction domain 3A | 2 | 2 | ||||||||
MIRT227670 | SET | SET nuclear proto-oncogene | 2 | 2 | ||||||||
MIRT293606 | PVR | poliovirus receptor | 2 | 2 | ||||||||
MIRT442923 | TFDP2 | transcription factor Dp-2 | 2 | 2 | ||||||||
MIRT447007 | RSF1 | remodeling and spacing factor 1 | 2 | 2 | ||||||||
MIRT450195 | ZHX3 | zinc fingers and homeoboxes 3 | 2 | 2 | ||||||||
MIRT450883 | COL4A5 | collagen type IV alpha 5 chain | 2 | 2 | ||||||||
MIRT459707 | ZNF641 | zinc finger protein 641 | 2 | 2 | ||||||||
MIRT467111 | SRI | sorcin | 2 | 2 | ||||||||
MIRT468271 | SFXN1 | sideroflexin 1 | 2 | 2 | ||||||||
MIRT484168 | WDR82P1 | WD repeat domain 82 pseudogene 1 | 2 | 8 | ||||||||
MIRT502274 | H3F3B | H3 histone family member 3B | 2 | 4 | ||||||||
MIRT504190 | FAM127B | retrotransposon Gag like 8A | 2 | 2 | ||||||||
MIRT507718 | CMPK1 | cytidine/uridine monophosphate kinase 1 | 2 | 6 | ||||||||
MIRT513852 | JARID2 | jumonji and AT-rich interaction domain containing 2 | 2 | 8 | ||||||||
MIRT521900 | PIAS1 | protein inhibitor of activated STAT 1 | 2 | 2 | ||||||||
MIRT525975 | SPA17 | sperm autoantigenic protein 17 | 2 | 2 | ||||||||
MIRT534599 | RORA | RAR related orphan receptor A | 2 | 2 | ||||||||
MIRT537572 | ESYT2 | extended synaptotagmin 2 | 2 | 2 | ||||||||
MIRT539261 | ANKRD44 | ankyrin repeat domain 44 | 2 | 2 | ||||||||
MIRT544214 | SRSF11 | serine and arginine rich splicing factor 11 | 2 | 4 | ||||||||
MIRT553877 | SUPT7L | SPT7 like, STAGA complex gamma subunit | 2 | 4 | ||||||||
MIRT564547 | CCDC80 | coiled-coil domain containing 80 | 2 | 2 | ||||||||
MIRT571228 | SYT9 | synaptotagmin 9 | 2 | 2 | ||||||||
MIRT572016 | H3F3C | H3 histone family member 3C | 2 | 2 | ||||||||
MIRT613116 | EIF4EBP2 | eukaryotic translation initiation factor 4E binding protein 2 | 2 | 2 | ||||||||
MIRT629028 | MMP16 | matrix metallopeptidase 16 | 2 | 4 | ||||||||
MIRT635228 | CD59 | CD59 molecule (CD59 blood group) | 2 | 2 | ||||||||
MIRT641493 | POLA2 | DNA polymerase alpha 2, accessory subunit | 2 | 2 | ||||||||
MIRT648008 | ZNF431 | zinc finger protein 431 | 2 | 2 | ||||||||
MIRT697344 | ZNF544 | zinc finger protein 544 | 2 | 2 | ||||||||
MIRT700991 | PDE3A | phosphodiesterase 3A | 2 | 2 | ||||||||
MIRT704714 | CHD9 | chromodomain helicase DNA binding protein 9 | 2 | 2 | ||||||||
MIRT705320 | ATP2A2 | ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | 2 | 2 | ||||||||
MIRT705387 | ATP1B3 | ATPase Na+/K+ transporting subunit beta 3 | 2 | 2 | ||||||||
MIRT715811 | NUDT7 | nudix hydrolase 7 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|